文章核心观点 - Leidos Holdings, Inc.（LDOS）盈利预期上升、ROE强劲且积压订单稳固，在Zacks航空航天板块提供了绝佳投资机会，是值得投资的股票 [1] 分组1：LDOS的增长预测与惊喜历史 - 过去60天里，Leidos 2024年每股收益（EPS）的Zacks共识估计提高了5.4%，达到8.95美元 [2] - 公司2024年总营收的Zacks共识估计为162.7亿美元，较2023年报告数据增长5.4% [2] - Leidos的长期（三到五年）盈利增长率为12.5%，过去四个季度的平均盈利惊喜为23.49% [2] 分组2：LDOS的股本回报率 - 目前LDOS的ROE为28.4%，高于行业平均的11.53%，表明公司比同行更有效地利用资金 [3] 分组3：Leidos的债务状况 - 公司目前的总债务与资本比率为50.9%，优于行业平均的55.29% [4] - 2024年第二季度末，Leidos的利息保障倍数（TIE）为4.5，大于1表明公司短期内能轻松履行利息支付义务 [4] 分组4：LDOS的流动性 - 2024年第二季度末，Leidos的流动比率为1.21，大于1表明公司能够轻松应对未来短期负债 [5] 分组5：Leidos的积压订单增长 - 从五角大楼和其他美国盟友获得的具有成本效益的军事技术合同是Leidos Holdings的关键收入来源，有助于增加公司的订单和积压订单 [6] - 截至2024年6月30日，Leidos的积压订单达到364.9亿美元，高于上一年的341.5亿美元，显著的积压订单趋势提高了公司未来几个季度的创收可能性 [6] 分组6：LDOS股价表现 - 过去六个月里，LDOS股价上涨了20.3%，而行业仅上涨1% [7] 分组7：其他可考虑的股票 - 同一板块的其他几只顶级股票包括Curtiss - Wright Corp.（CW）、BAE Systems（BAESY）和Leonardo DRS, Inc.（DRS），目前均为Zacks排名第二（买入） [9] - Curtiss - Wright过去四个季度的平均盈利惊喜为11.52%，2024年总营收的Zacks共识估计为30.5亿美元，较2023年报告数据增长7% [10] - BAE Systems的长期盈利增长率为12.4%，2024年销售额的Zacks共识估计为358.4亿美元，较2023年报告销售额增长36.3% [10] - Leonardo DRS的长期盈利增长率为16.4%，2024年总营收的Zacks共识估计为31.5亿美元，同比增长11.4% [11]

RESTON, Va., Sept. 18, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 innovation company, announced that Tina Jonas has been appointed to the company's Board of Directors, effective September 25, 2024. She will also join the Board's Audit and Finance Committee. Jonas is a recognized expert in military, defense and aerospace issues. Her background includes transformational leadership, strategy and planning, business development, operations, finance and technology deployment at the highest levels in ...

文章核心观点 Leidos公司成功进行无人机系统和巡航导弹测试目标拦截，Enduring Shield完成重要测试并获新合同，还获美国陆军额外硬件资产合同以支持陆军持久间接火力防护能力初始作战测试与评估 [1][2][3] 测试成果 - Leidos与相关部门用间接火力防护能力增量2系统成功拦截无人机系统和巡航导弹测试目标 [1] - Enduring Shield完成重要测试，展示系统用地面发射AIM - 9X在导弹飞行测试中探测、跟踪、交战和拦截无人机系统和巡航导弹目标的能力，还涉及集成综合战斗指挥系统、哨兵A3和导弹数据链，通过实弹射击展示中和目标能力 [2] 合同情况 - Leidos获美国陆军合同司令部红石兵工厂合同，为陆军持久间接火力防护能力初始作战测试与评估提供额外硬件资产 [3] - 硬件包括导弹远程通信链路和软件升级，支持陆军综合防空和导弹防御架构 [4] 系统介绍 - IFPC Inc 2是地面移动系统，旨在对抗巡航导弹和无人机系统，是保护关键民用和军事基础设施解决方案的关键部分，还旨在弥合战术近程防空与战略系统之间的差距 [5] 公司概况 - Leidos是财富500强创新公司，在国家安全和健康领域应对挑战，全球有48000名员工，为受严格监管行业客户提供技术解决方案，总部位于弗吉尼亚州雷斯顿，2023财年报告年收入约154亿美元 [7]

文章核心观点 - 公司过去几个季度财务表现强劲，股价自2月以来上涨近40%，虽面临英国业务减记和VBA合同不确定性等挑战，但基于良好财务结果、管理层信心等因素，维持买入评级，建议密切关注VBA合同重新竞标的情况 [2][11][12] 公司概述 - 公司是一家美国公司，为国防、民用和医疗市场提供技术解决方案和服务，2023年约87%的收入来自美国政府机构 [4] - 公司通过三个业务部门运营，分别为国防、民用和医疗，其中国防是主要部门，2023年占总收入的56% [4] - 2023年公司9%的年收入来自国际客户，主要来自英国和澳大利亚；公司26名董事和高管共持有0.96%的普通股，且无持股5%的大型私募股权公司 [6] 近期表现 - 公司英国业务因两份合同问题减记3900万美元，导致国际业务部门运营利润率为 -2%，若不考虑减记，运营利润率可达8% [8] - VBA合同面临资金挑战和重新竞标阶段的不确定性，可能影响公司未来该业务板块的收入 [8] - 公司第二季度业绩良好，营收同比增长8%至41亿美元，健康与民用业务板块营收同比增长22%，运营利润率从13.0%大幅提升至24.3% [8] - 管理层上调2024年全年业绩指引，将营收指引下限提高1亿美元，非GAAP摊薄后每股收益指引上调至8.60 - 9.00美元 [8] 前景展望 - 自2024年2月以来股价呈牛市走势，突破110美元阻力位后上涨近40%，RSI指标显示超买迹象 [9] - 公司自2023年第一季度以来EBITDA和营业收入持续增长，自2023年第二季度以来有正的自由现金流，偿债能力良好 [11] - 管理层承诺年底前回购5亿美元股票，截至第二季度已完成一半，首席执行官于8月1日进行了24.8305万美元的内幕买入 [11]

Leidos (LDOS) closed the most recent trading day at $152.85, moving -1.89% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 1.73%. On the other hand, the Dow registered a loss of 1.01%, and the technology-centric Nasdaq decreased by 2.55%. Prior to today's trading, shares of the security and engineering company had gained 7.91% over the past month. This has outpaced the Aerospace sector's gain of 5.73% and the S&P 500's gain of 6.22% in that time. The investm ...

Leidos (LDOS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, LDOS broke through the 200-day moving average, which suggests a long-term bullish trend. A useful tool for traders and analysts, the 200-day simple moving average helps determine long-term market trends for stocks, commodities, indexes, and other financial instruments. It moves higher or lower in conjunction with longer-term price performance, and serves as a support or resistanc ...

RESTON, Va., Sept. 3, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN) Development, Maintenance, Support, and Modernization contract by the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases. Leidos will leverage its data management and mission software expertise to continue delivering a secure NHSN platform, including the necessary support applications a ...

It has been about a month since the last earnings report for Leidos (LDOS) . Shares have added about 8.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Leidos due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Leidos Holdings Beats on Q2 Earnings, Ups '24 EPS View ...

Leidos Holdings, Inc. (LDOS) recently clinched a contract for Missile Warning/Missile Track Enhancement (MW/MT) from the Space Systems Command, Strategic Warning and Surveillance Systems Acquisition Delta. The value of the award is $51 million. Per the terms of the contract, Leidos will deliver mission software and technology-enabled services to improve missile warning capabilities for the Combatant Commanders' Integrated Command and Control Systems. What's Favoring LDOS? Rapidly increasing geopolitical ten ...

RESTON, Va., Aug. 27, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation leader, was recently awarded a Missile Warning/Missile Track Enhancement (MW/MT) contract by the Space Systems Command, Strategic Warning and Surveillance Systems Acquisition Delta. Leidos will provide mission software and technology-enabled services to enhance missile warning capabilities for the Combatant Commanders Integrated Command and Control Systems (CCIC2S). The award has a base period of performance of 54 month ...